OPUS 4 Latest Documents RSS Feed Latest documents http://publikationen.ub.uni-frankfurt.de/index/index/ Sun, 20 Sep 2009 11:01:42 +0200 Sun, 20 Sep 2009 11:01:42 +0200 The Rainbow Cohort: saquinavir/r is effective and well tolerated in antiretroviral therapy (ART)-naïve patients – 48-week results from Germany http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7051 Poster presentation: Purpose of the study The aim of the Rainbow Cohort is to assess the tolerability and efficacy of initiating treatment with, or switching treatment to saquinavir (SQV) 500 mg film-coated tablet formulation. We present the final 48-week subgroup analysis of antiretroviral therapy (ART)-naïve patients. ... Heribert Knechten; Christoph Stephan; Thomas Lutz; Albrecht Stoehr; Andreas Carganico; Gaby Knecht; Carl Knud Schewe; Hans Jaeger; Christoph Mayr; Franz Mosthaf; Eva Wolf; Egbert Wellmann; Andre Tappe article http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7051 Sun, 20 Sep 2009 11:01:42 +0200 Antiretroviral tolerability and efficacy after switch to saquinavir in PI-experienced patients : 48-week analysis of the German Rainbow Cohort http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7058 Poster presentation: Purpose of the study The aim of the Rainbow Cohort is to assess the tolerability and efficacy of initiating treatment with, or switching treatment to the saquinavir (SQV) 500 mg film-coated tablet formulation. We present the final 48-week subgroup analysis of PI-experienced, but SQV-naïve patients. ... Christoph Stephan; Hans Jäger; Andreas Carganico; Gaby Knecht; Thomas Lutz; Christoph Mayr; Franz Mosthaf; Siegfried Koeppe; Markus Mueller; Eva Wolf; Andre Tappe; Egbert Wellmann; Heribert Knechten article http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/7058 Sun, 20 Sep 2009 00:00:00 +0200